773: Low molecular weight heparin (LMWH) versus no treatment in women with previous severe preeclampsia, fetal growth restrictin, severe placental abruption, stillbirth and placental findings without thrombophilia

2009 ◽  
Vol 201 (6) ◽  
pp. S278
Author(s):  
Michael Kupferminc ◽  
Eliyahu Rimon ◽  
Sharon Malovitz ◽  
Joseph B. Lessing ◽  
David Pausner ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Fetal Growth ◽  
Low Molecular Weight Heparin ◽  
Placental Abruption ◽  
Severe Preeclampsia ◽  
Low Molecular Weight

scholarly journals Current Theories on the Prevention of Severe Preeclampsia With Low-Molecular Weight Heparin

Hypertension ◽  
2015 ◽  
Vol 66 (6) ◽  
pp. 1098-1103 ◽  
Author(s):  
Kelsey McLaughlin ◽  
Sascha Drewlo ◽  
John D. Parker ◽  
John C.P. Kingdom
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Severe Preeclampsia ◽  
Low Molecular Weight

Angiogenic Factor Profiles in Pregnant Women With a History of Early-Onset Severe Preeclampsia Receiving Low-Molecular-Weight Heparin Prophylaxis

2018 ◽  
Vol 131 (1) ◽  
pp. 63-69 ◽  
Author(s):  
Edouard Lecarpentier ◽  
Jean Christophe Gris ◽  
Eva Cochery-Nouvellon ◽  
Erick Mercier ◽  
Cyril Touboul ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Pregnant Women ◽  
Early Onset ◽  
Low Molecular Weight Heparin ◽  
Severe Preeclampsia ◽  
Angiogenic Factor ◽  
Low Molecular Weight ◽  
History Of ◽  
Heparin Prophylaxis
Sign in / Sign up

Export Citation Format

Share Document